<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43">
 <label>43</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Severance</surname>
    <given-names>EG</given-names>
   </name>
   <name>
    <surname>Bossis</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Dickerson</surname>
    <given-names>FB</given-names>
   </name>
   <name>
    <surname>Stallings</surname>
    <given-names>CR</given-names>
   </name>
   <name>
    <surname>Origoni</surname>
    <given-names>AE</given-names>
   </name>
   <name>
    <surname>Sullens</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Yolken RH and Viscidi</surname>
    <given-names>RP</given-names>
   </name>
  </person-group>
  <article-title>Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population.</article-title>
  <source>Clin Vaccine Immunol</source>
  <year>2008</year>
  <volume>15</volume>
  <issue>12</issue>
  <fpage>1805</fpage>
  <lpage>1810</lpage>
  <pub-id pub-id-type="doi">10.1128/cvi.00124-08</pub-id>
  <pub-id pub-id-type="pmid">18945884</pub-id>
 </element-citation>
</ref>
